Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centersAndrew M. Evens, Matthew A. Lunning, Alexey V. Danilov et al.|Blood|2021Cited by 125
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysisJuan Pablo Alderuccio, Tatyana Feldman, Adam J. Olszewski et al.|Blood Advances|2021Cited by 54
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphomaJuan Pablo Alderuccio, Izidore S. Lossos, Luca Arcaini et al.|Blood Advances|2022Cited by 34
Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter studySwaminathan P. Iyer, Bradley M. Haverkos, Juan Pablo Alderuccio et al.|Haematologica|2023Cited by 24